Lv1
5 积分 2021-01-21 加入
Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia
8天前
已完结
Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease
9天前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
14天前
已完结
Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers
14天前
已完结
Overcoming triple mutant EGFR-tyrosine kinase barriers in the therapeutics of non-small cell lung cancer: a patent review on fourth-generation inhibitors (2017–2024)
17天前
已完结
A clinical review on third and fourth generation EGFR tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
17天前
已完结
[Chinese guideline for diagnosis and management of drug-induced liver injury (2023 version)]
21天前
已完结
Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia
1个月前
已完结
Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA‐AUT
1个月前
已完结
Emerging disease-modifying therapies for Angelman syndrome: A comprehensive review for pediatric neurologists
2个月前
已完结
皖公网安备34019202002308
